These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983. Forsgren A, Walder M. Acta Otolaryngol Suppl; 1984 Oct; 407():43-9. PubMed ID: 6437134 [Abstract] [Full Text] [Related]
9. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. Biedenbach DJ, Jones RN, Lewis MT, Croco MA, Barrett MS. Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755 [Abstract] [Full Text] [Related]
10. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus. Nord CE, Lindmark A, Persson I. J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369 [No Abstract] [Full Text] [Related]
11. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States. Pfaller MA, Farrell DJ, Sader HS, Jones RN. Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951 [Abstract] [Full Text] [Related]